After Pfizer launched yet another takeover bid for AstraZeneca (LSE: AZN) (NYSE: AZN.US) and the latter turned it down once more, Jill Ralph and Nate Weisshaar take a closer look at the UK-based pharmaceutical company in this investing video, and ask what Astra shareholders should be doing now…
A Closer Look At AstraZeneca plc
VIDEO: Two Fools put AstraZeneca plc (LON:AZN) under the spotlight.
The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.
You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.